Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.81%231.58B | -3.50%1.03T | -3.92%728.4B | -5.22%489.2B | -6.61%256.76B | -6.22%1.07T | -5.99%758.13B | -4.61%516.14B | 0.52%274.95B | 3.80%1.14T |
| Operating income | -9.81%231.58B | -3.50%1.03T | -3.92%728.4B | -5.22%489.2B | -6.61%256.76B | -6.22%1.07T | -5.99%758.13B | -4.61%516.14B | 0.52%274.95B | 3.80%1.14T |
| Operating expenses | 10.15%-213.39B | 2.92%-929.67B | 3.51%-664.5B | 4.93%-445.94B | 6.33%-237.49B | 6.09%-957.6B | 5.99%-688.69B | 4.83%-469.07B | -0.49%-253.54B | -3.45%-1.02T |
| Gross profit | -5.62%18.19B | -8.63%100.12B | -7.97%63.9B | -8.08%43.26B | -9.99%19.27B | -7.34%109.57B | -6.06%69.43B | -2.33%47.07B | 0.76%21.41B | 6.95%118.24B |
| Selling expenses | 17.16%-1.07B | 6.20%-6.41B | 8.88%-3.89B | 8.50%-2.71B | 15.74%-1.29B | 6.51%-6.84B | 10.74%-4.26B | 10.64%-2.96B | 5.13%-1.54B | -10.08%-7.31B |
| Administrative expenses | 18.43%-4.14B | 9.81%-20.14B | 9.86%-13.46B | 9.73%-9.24B | 13.31%-5.08B | 4.85%-22.33B | 5.51%-14.93B | 2.86%-10.24B | -4.00%-5.86B | -7.28%-23.47B |
| Research and development expenses | 19.89%-2.36B | 8.23%-23.6B | 12.84%-13.18B | 12.71%-7.52B | -4.30%-2.94B | 3.79%-25.71B | -2.69%-15.12B | -3.83%-8.61B | 3.64%-2.82B | -6.88%-26.73B |
| Profit from asset sales | 375.34%50.78M | 37.19%391.08M | -56.24%102.41M | -70.67%49.04M | -73.87%10.68M | -57.54%285.07M | 138.80%234.02M | 221.84%167.21M | 78.46%40.89M | 783.07%671.46M |
| Revaluation surplus | -599.82%-140.31M | 28.34%-1.05B | 22.51%-328.88M | 30.59%-193.13M | -162.88%-20.05M | -127.92%-1.47B | -4,287.62%-424.41M | -2,123.07%-278.24M | -31.68%31.89M | -39.12%-643.56M |
| -Changes in the fair value of other assets | -599.82%-140.31M | 28.34%-1.05B | 22.51%-328.88M | 30.59%-193.13M | -162.88%-20.05M | -127.92%-1.47B | -4,287.62%-424.41M | -2,123.07%-278.24M | -31.68%31.89M | -39.12%-643.56M |
| Impairment and provision | -98.30%-867.43M | 1.94%-8.92B | -6.50%-2.83B | -6.36%-2.41B | 5.71%-437.44M | 8.50%-9.1B | 31.29%-2.66B | -15.96%-2.26B | 21.43%-463.94M | -25.22%-9.94B |
| -Other impairment is provision | -98.30%-867.43M | 1.94%-8.92B | -6.50%-2.83B | -6.36%-2.41B | 5.71%-437.44M | 8.50%-9.1B | 31.29%-2.66B | -15.96%-2.26B | 21.43%-463.94M | -25.22%-9.94B |
| Special items of operating profit | 2,132.56%729.09M | 351.18%1.39B | 135.17%82.15M | 42.06%-384.98M | -17.64%32.66M | 83.07%-554.62M | 90.65%-233.57M | 54.21%-664.41M | 116.69%39.65M | 8.18%-3.28B |
| Operating profit | 9.70%9.58B | -6.16%37.75B | -6.06%27.96B | -6.16%19.38B | -13.22%8.74B | -6.99%40.23B | -1.06%29.76B | -2.41%20.66B | 5.06%10.07B | 5.55%43.26B |
| Financing income | -31.32%807.23M | 4.47%3.94B | 9.91%2.73B | 8.50%1.83B | 46.46%1.18B | -10.65%3.77B | -15.39%2.48B | -17.93%1.68B | -21.57%802.52M | -4.00%4.22B |
| Financing cost | -11.99%-3.05B | -35.68%-13.07B | -29.89%-9B | -37.93%-5.8B | -40.10%-2.72B | -29.17%-9.64B | -47.93%-6.93B | -34.33%-4.2B | -19.09%-1.94B | -21.42%-7.46B |
| Special items of earning before tax | 22.97%56.15M | -19.36%154.42M | 266.37%218.42M | 44.67%234.27M | 332.30%45.66M | -18.32%191.48M | -70.10%59.62M | 8.42%161.94M | -126.89%-19.66M | -44.56%234.44M |
| Earning before tax | -19.80%5.96B | -17.06%26.93B | -13.88%20.46B | -14.04%15.35B | -13.96%7.43B | -16.36%32.47B | -14.22%23.76B | -9.42%17.86B | 1.39%8.63B | 2.65%38.83B |
| After-tax profit from continuing operations | -19.68%4.9B | -19.91%21.69B | -13.69%17.23B | -16.02%12.56B | -13.98%6.1B | -16.24%27.08B | -14.70%19.96B | -9.30%14.96B | 2.82%7.09B | 1.68%32.33B |
| Earning after tax | -19.68%4.9B | -19.91%21.69B | -13.69%17.23B | -16.02%12.56B | -13.98%6.1B | -16.24%27.08B | -14.70%19.96B | -9.30%14.96B | 2.82%7.09B | 1.68%32.33B |
| Minority profit | -46.52%508.15M | -31.65%3.32B | -43.33%2.42B | -39.12%1.86B | -10.96%950.22M | -21.96%4.86B | 7.10%4.27B | 7.50%3.06B | 7.85%1.07B | 21.87%6.23B |
| Profit attributable to shareholders | -14.72%4.39B | -17.34%18.36B | -5.63%14.81B | -10.09%10.7B | -14.51%5.15B | -14.87%22.22B | -19.18%15.7B | -12.80%11.9B | 1.98%6.03B | -2.19%26.1B |
| Basic earnings per share | -17.65%0.28 | -19.18%1.18 | -5.88%0.96 | -11.39%0.7 | 0.00%0.34 | -15.61%1.46 | -20.93%1.02 | -13.19%0.79 | -12.60%0.34 | -1.70%1.73 |
| Diluted earnings per share | -17.65%0.28 | -19.18%1.18 | -5.88%0.96 | -11.39%0.7 | -14.79%0.34 | -15.61%1.46 | -20.93%1.02 | -13.19%0.79 | 2.57%0.399 | -1.70%1.73 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming Accounting Firm (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.